Robert Beal past director of International Federation of Red Cross Transfusions History 1660s First experiments in blood transfusion transfused dog blood to humans Patient died and experiments were banned ID: 934254
Download Presentation The PPT/PDF document "Transfusion Medicine “Blood transfusio..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Transfusion Medicine
Slide2“Blood transfusion is like marriage: it should not be entered upon lightly, unadvisedly or wantonly or more often than is absolutely necessary
.”
–Robert Beal, past director of International Federation of Red Cross
Slide3Transfusions: History
1660s: First experiments in blood transfusion, transfused dog blood to humans. Patient died and experiments were banned.
1818: James Blundell, British OBGYN, inspired after seeing women bleed to death from uterine losses. Successfully did human transfusions. Mortality up to 50% likely due to ABO incompatibility.
1900: Karl Landsteiner discovered ABO blood groups.
1940: Red Cross established to help supply blood products during WWII.
Slide4Blundnell’s
gravitator
(1818)
“On the transfusion of blood by the syringe.”
Source: Blood Journal
Slide5Blood components & products
Whole blood
Red blood cells (
P
RBCs)
Fresh frozen plasma (FFP)
Cryoprecipitated
AHF
Platelets
Granulocytes
Slide6Blood Collection: whole blood
Slide7Blood collection:
apheresis (“a taking away”)
Slide8Red Blood Cells
Slide9Red blood cells
Slide10Red blood cell transfusion
Indications for transfusion
Symptomatic anemia
Red blood cell exchange
Action
Increases oxygen carrying capacity by increasing circulating red cell mass
Dosing
Each unit contains enough
Hgb
to increase by about 1 g/
dL
Each unit contains 250 mg of iron
Administration
Must be ABO compatible
ABO/Rh typing, Ab screen,
crossmatch
Initial portion of each unit transfused slowly to look for reactions, then infusion can be as rapid as tolerated
Finish transfusion within 4 hours (do not leave at room temp > 4
hrs
)
Slide11Transfusion of Blood Products
Collections and Storage of
pRBCs
Half Life of stores platelets is somewhat shorted than normal expected RBC lifespan (120 days)
Lifespan of transfused red cells closer to 50-60 days
Thought 2/2 to depletion of 2,3 DPG
Stores of ATP are diminished in stored RBCs
Slide12Blood Groups - ABO
First described by Karl Landsteiner in 1900
Won the Nobel Prize in Medicine for his work
First successful, “matched” blood transfusion was done by Dr. Reuben
Ottenberg
at Mt. Sinai Hospital in 1907.
Slide13Blood Groups - ABO
Carbohydrate antigens in which the alleles are determined by the end moiety
Addition of n-
acetylgalactomine
to the base structure yields blood group A
Addition of galactose to the base structure (a galactose moiety) yields blood group B
Lack of any additional moieties yields blood group O
Slide14Slide15Slide16Minor Antigen Groups
Slide17Rh Blood Groups
RH Blood
Group
2
nd
most important after ABO
Consists of 50
antigens
D
, C, c, E, e are most important
RH positive vs negative refers to the presence of absence of the D antigen
Part of the routine Type and Screen and Crossmatch
antigens that we test for
Slide18RH Blood Group
Most clinically relevant in hemolytic disease of the newborn
An Rh negative mother with an Rh positive father can result in an Rh positive child
Exposure of fetal cells to mother creates anti-D Abs
Use of
RhoGAM
has reduced the incidence from close to 16% down to less than 1%
Given at week 28-30 and again within 72
hrs
postoperatively
Slide19Blood Groups
Type and Screen
Front type: what antigens are on the patient’s RBCs
Back type: identify Ab in the patient’s serum
A antigen only
Type A
B antigen only
Type B
A and B
antigen
Type AB
Neither A or B
Type O
anti-B
Type A
anti-A
Type B
anti-A and anti-B
Type O
neither anti-A or anti-B
Type AB
Slide20Screen
Look for red cell alloantibodies that may have formed in pregnancy or after prior transfusions
If screen is positive, need to identify the Ab
Slide21Blood Groups
Type and Cross
Crossmatching
involves actually taking donor red cells and mixing with a portion of the patient’s serum to look for a
reaction
At least 2 units of PRBCs are
crossmatched
for the patient and reserved for the patient – these units cannot be used by anyone else
Slide22Blood Groups - ABO
So why are these important in transfusion medicine?
Slide23Complications of RBC transfusion
Acute hemolytic
transfusion reaction
Febrile
nonhemolytic
transfusion reaction
Allergic reaction
Anaphylactic reaction
Transfusion related acute lung injury (TRALI
)
TACO
Iron overload
Slide24Blood Groups - ABO
Acute Hemolytic Transfusion Reaction
Due to ABO incompatibility
Usually due to human
ID errors (mislabeling)
Symptoms
Classic
Triad: Fevers/Chills
, Flank Pain and Red
Urine
Also dyspnea, chest/back pain, shock
If patient is in surgery under anesthesia: red urine, hypotension, DIC
Slide25Slide26Lab findings:
Hemoglobinuria
E
levated bilirubin
P
ositive DAT/Direct
Coomb’s
Treatment: supportive
Stop transfusion immediately
Notify blood bank to review
Send blood sample from patient along with implicated unit
Maintain/correct BP
Correct coagulopathy, if presentPromote and maintain urine flow
Slide27Delayed transfusion reaction
Occur in patients who are previously
alloimmunized
Antigens on transfused cells provoke antibody production
Usually occurs 2-14 days after transfusion
Signs/symptoms: fever, positive DAT, decrease in H&H, elevated LDH and
bili
Most times this is benign and requires no treatment
Slide28Transfusion
Febrile
nonhemolytic
transfusion reaction
Fever shortly after transfusion (without infection)
Due to cytokines or Abs against WBCs in the transfused blood
More likely to occur if
alloimmunized
during pregnancy or previous transfusion
Reduce occurrence by using leukocyte reduced RBCs
or platelets
Incidence: in less than 1% of LR-RBCs and less than 5% of LR-platelets
Slide29Anaphylactic reactions
Reported in IgA deficient patients who develop Abs to IgA
Symptoms: hypotension, tachycardia, N/V, diarrhea, bronchospasm, laryngospasm
Use epinephrine, supportive care
Reduce incidence: use washed cellular components
Slide30TRALI
Thought to be caused by WBC Abs in donors or inflammatory molecules in blood product
Stimulate an inflammatory response in a “primed” donor
Cause injury to alveolar capillary membrane, increased permeability, pulmonary edema
Symptoms: acute onset of hypoxia and non-cardiogenic pulmonary edema within 6
hrs
of a transfusion
Treatment: Aggressive supportive care
Reduce occurrence by
leukoreducing
blood products and preferentially using plasma donated by males.
Slide31TACO
Circulatory overload leading to pulmonary edema
Occurs after transfusing high volumes or at very rapid rates
Higher risk in people with underlying cardiopulmonary or renal disease, very young or elderly, and people with chronic anemia who have low red cell mass and high plasma volume
Treat: supportive, reduce pulmonary edema
Slide32Bacterial sepsis
Due to gram negative or positive organisms in the transfused product, often skin contaminants
Symptoms: high fever, hypotension, shock during or shortly after transfusion
Treat: stop transfusion, give
abx
and
pressors
prn. Send blood
cxs
from patient and culture specimens from container and blood administration set, report to blood bank.
Occurs more often with platelets (stored at room temp). Most platelets are routinely tested for bacterial contamination.
Slide33Infectious risks
Infection transmission
Blood products are all tested for:
HIV (1 in 1,000,000)
HTLV I and II (1 in 2,000,000)
Hepatitis B (1 in 200,000)
Hepatitis C (1 in 1,000,000)
Syphilis (
treponema
pallidum
)
West Nile VirusChagas (trypanosome cruzi
)
Other risks: CMV, malaria, bacteria, Lyme, Dengue,
Babesiosis
,
Creutzfeld-Jakob
Slide34Blood components & products
Whole blood
Red blood cells (
P
RBCs)
Fresh frozen plasma (FFP
)
Cryoprecipitated
AHF
Platelets
Granulocytes
Slide35Fresh Frozen Plasma
Plasma: FFP
Contains all plasma proteins including all coagulation factors
10-15 mL/kg raises factors ~25%
Ready to use after thawing, must be discarded after 24
hrs
or stored as thawed plasma
Indications for use
Preop
or bleeding patients who need replacement of multiple factors (liver disease, DIC)
Patients taking warfarin who need transient reversal of warfarin before
Vit
K would take effect
TTP (transfuse or plasma exchange)
Patients with plasma protein or factor deficiencies, if no specific factor concentrate or recombinant product is available
Slide36Fresh Frozen P
lasma
FFP precautions
One unit is about 250 mL (can be up to 600 mL if apheresis derived). High risk for volume overload.
Plasma must be ABO compatible with the patient’s red cells.
Average INR of FFP is 1.5. Will not correct INR below this value.
Slide37Fresh Frozen Plasma
FFP: complications/hazards
Infection (bacterial, viral)
Allergic reactions
Febrile reactions
TACO
TRALI
Slide38Blood components & products
Whole blood
Red blood cells (
P
RBCs)
Fresh frozen plasma (FFP)
Cryoprecipitated
AHF
Platelets
Granulocytes
Slide39Cryoprecipitate
Cryoprecipitated
anti-hemophilic factor
That FFP
recover the precipitate
Contains:
Fibrinogen
Factor VIII
Factor XIII
vWF
Fibronectin
Each unit contains 80 IU Factor VIII and 150 mg fibrinogen in 5-20 mL plasma
Slide40Cryoprecipitate
Indications:
Control bleeding due to low fibrinogen
Treat Factor VIII deficiency when recombinant proteins not available
Second line therapy for
vWD
and hemophilia A
ABO compatible preferred
Dose: 1 bag per 10 kg of body weight will raise fibrinogen by 50-75 mg/
dL
Slide41Blood components & products
Whole blood
Red blood cells (
P
RBCs)
Fresh frozen plasma (FFP)
Cryoprecipitated
AHF
Platelets
Granulocytes
Slide42Platelet Transfusions
Platelets needed for normal hemostasis
Platelets are collected from a single donor (separated from whole blood) or
pheresed
and pooled from different donors (1 unit = 4-6 single donor units)
Slide43Platelet Transfusions
Indications for transfusion:
Thrombocytopenia
Dysfunctional platelet bleeding
Active platelet related bleeding
Prophylactic use for high risk of bleed
Hematologic conditions
Patients on ECMO or cardiopulmonary bypass
Do not use:
In HIT, TTP, or ITP, unless patient has significant bleeding
Slide44Platelet Transfusions
Compatibility testing not routinely necessary
Therapeutic dose:
1 unit apheresis platelets
4-6 units of whole blood derived platelets
Should raise platelets by 5-10k
Transfused platelets have a short lifespan! 3-5 days
Slide45Platelet Transfusions
Platelet
alloimmunization
Platelets have HLA and platelet specific antigens on their surface
Patients who get transfusions often develop HLA antibodies and may become refractory to platelets
Check CBC 10-60 minutes post transfusion
if Abs present, will not see response
If poor response is due to splenomegaly, sepsis, fever, or DIC, will usually see early response to transfusion but reduced 24
hr
survival
Can do tests to look for presence of Ab against platelet antigens
Slide46Factor Concentrates
Prothrombin Complex Concentrate (PCC)
Contains Vitamin K dependent factors (II, VII,
I
X, X)
Used to reverse the effects of Vitamin K antagonists
Slide47Special scenarios
Massive transfusion for severe hemorrhage (trauma)
Transfuse RBCs, platelets, plasma in 1:1:1 ratio
Need FFP otherwise clotting factors will be diluted and worsen coagulopathy
Blood is
anticoagulated
with sodium citrate and citric acid.
In massive transfusion, can get metabolic alkalosis and
hypocalcemia
from excessive citrate.
Hypothermia can develop when transfusing more than 3 units
use a blood warmer.